CD8A and cancer: Reliance on the Zhang CD8 TCS signature for all cancers as a prognostic indicator for OS and PFI could provide valuable insight into future cancer behavior; however, our study demonstrates the importance of consideration of numerous published signatures tailored to tumor type and origin to better inform patient-centered decision-making.